Up next

Autoplay

The TRUTH About Oral RYBELSUS (Obesity Doctor)

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

The TRUTH about Oral RYBELSUS from a physician board certified in obesity medicine. Wouldn't it be great to have an oral form of weight medication that worked as well as the injectable forms? A study from 2023 sheds light on some promising results. What do you think? Have you tried Rybelsus?

Work with me: www.weightmedicinemd.com

References
Filip K Knop 1 et al; OASIS 1 Investigators. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Aug 26;402(10403):705-719. PMID: 37385278

JPH Wilding et al. STEP 1 Trial. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. PMID: 33567185

Blazer: @tibi
Candle: @kristinabraly www.aembr.co

The information in this video is intended to serve as educational information and is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained in this video is for general information purposes only and does not replace a consultation with your own doctor.

Show more
0 Comments sort Sort By

Up next

Autoplay